Omnicell
OMCL
177 hedge funds and large institutions have $897M invested in Omnicell in 2014 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 65 increasing their positions, 65 reducing their positions, and 11 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
55% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 11
3% more funds holding
Funds holding: 172 → 177 (+5)
0% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 65
6% less capital invested
Capital invested by funds: $958M → $897M (-$61.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$15M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$11.7M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$3.68M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$3.5M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$3.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$18M |
| 2 |
BSA
Braun Stacey Associates
New York
|
-$13.3M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$13.1M |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
-$7.82M |
| 5 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
-$4.53M |
OMCL Hedge Fund Activity: Q3 2014 in Review
177 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q3 2014, worth a combined $897M — down 6.4% from $958M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new OMCL positions and 11 closed out — a net gain of 6 holders — while 65 added to existing stakes and 65 trimmed.
The largest buyer was OppenheimerFunds, opening a new position worth an estimated $15M. The largest seller was JP Morgan Chase, cutting an estimated $18M.
- 177 institutional investors held Omnicell (OMCL) as of Q3 2014, up from 172 in Q2 2014.
- Funds reported $897M of Omnicell stock for Q3 2014, down 6.4% quarter-over-quarter.
- 17 funds opened new Omnicell positions in Q3 2014 and 11 closed out, a net change of +6 holders.
- The largest Omnicell buyer in Q3 2014 was OppenheimerFunds, an estimated $15M added.
- The largest Omnicell seller in Q3 2014 was JP Morgan Chase, an estimated $18M sold.
Based on aggregated 13F filings for Q3 2014.